What if your healthcare allocation could deliver alpha and fund life-saving research at the same time? In this episode, we sit down with Mike Taylor—a scientist-turned–hedge fund manager who now runs PINK, an actively managed healthcare ETF that donates its net fees and his compensation to the Susan G. Komen Foundation—to explore how performance, purpose, and rigorous stock picking can live under one ticker. Mike walks us through his nonlinear path from gene therapy labs to top seats at Oppenheimer, Citadel, and Millennium, and why healthcare's complexity creates opportunity for specialists. We dig into the sector's under-ownership despite being ~18% of GDP, the acceleration of drug development from seven years to under three, and the emerging longevity wave that could redefine productivity and portfolio design. Along the way, Mike explains why most savers can't behave like mythical "long-term investors," what Buffett's float really taught us about cost of capital, and how active managers can pragmatically focus on the next 6–24 months while compounding over years. We also zoom out to the macro frame: demographics, money printing, bond suppression, and the silent wealth transfers of inflation. From Japan's currency saga to strains on the Euro and the implications for the dollar, gold, and EM flows, Mike argues for ignoring the noise and following data and dollars. Healthcare, with its uncorrelated subsectors and rapid innovation, offers fertile ground for disciplined alpha—and PINK aims to capture it while doing measurable good. KEY TOPICS: PINK's mission: 100% net fees to breast cancer research Active management across biopharma, medtech, services Why healthcare is under-owned yet rich with alpha Drug development acceleration and longevity economics Buffett's float and the long-term investor myth Demographics, money printing, and bond market realities Japan, Euro risks, dollar, and gold dynamics Pragmatic investing: trade what is, not what should be Find Du Charme Wealth Management here: https://ducharmewealth.com Phone: (435) 288-3396 DISCLAIMER: Information presented on this program is believed to be factual and up-to-date, but we do not guarantee its accuracy, and it should not be regarded as a complete analysis of the subjects discussed. Discussions and answers to questions do not involve the rendering of personalized investment advice, but are limited to the dissemination of general information. A professional advisor should be consulted before implementing any of the options presented. Encompass More Asset Management LLC is a registered investment adviser with the U.S. Securities and Exchange Commission (SEC) and only transacts business in states where it is properly registered, or is excluded or exempted from registration requirements. [00:00:00] Disclaimers And Opening [00:06:56] Mike's Nonlinear Career Path [00:16:40] Drug Development Speed And Innovation [00:23:00] Time Horizons: Buffett, Float, And Reality [00:36:20] Compounding Alpha And Benchmarks [00:48:20] Central Banks, Data, And Liquidity [00:53:30] Debt, Taxes, And Financial Repression [01:08:20] Pragmatism: Trade What Is [01:16:40] Closing Notes And Ways To Connect
